DNDI-6510
DNDI-6510 (Compound (S) -x38) is a non-covalent SARS-CoV-2 MPro inhibitor with a IC50 of 0.04 μM. DNDI-6510 has a potent antiviral activity across SARS-CoV-2 and its variants as well as a weak efficacy to SARS-CoV-1. DNDI-6510 significantly improves drug exposure in metabolically humanized mice model (8HUM) [1].
Product Specifications
UNSPSC
12352005
Target
Cytochrome P450; SARS-CoV; Virus Protease
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Field of Research
Infection
Smiles
CNC(C1(CC1)N2C[C@@]3(C4=C(C2=O)C=CC(Cl)=C4)CCN(C3=O)C5=C6C=CC=CC6=CN=C5)=O
Molecular Formula
C26H23ClN4O3
Molecular Weight
474.94
References & Citations
[1]Griffen E J, et al. Open-science discovery of DNDI-6510, a compound that addresses genotoxic and metabolic liabilities of the COVID Moonshot SARS-CoV-2 Mpro lead inhibitor[J]. bioRxiv, 2025: 2025.06. 16.660018.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CYP2; CYP3
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
129338-ML550 100 µL
MAML2 (Mastermind-like Protein 2, Mam-2, KIAA1819, DKFZp686N0150, MGC176701, MLL-MAML2) (MaxLight 550)
Sign In for Pricing
View Details 
orb1717519-01 50 µL
M1-linkage Specific Polyubiquitin polyclonal antibody
Sign In for Pricing
View Details orb1717519-02 100 µL
M1-linkage Specific Polyubiquitin polyclonal antibody
Sign In for Pricing
View Details 
12517066 1.0 µg DNA
ASB7 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details 
39140096 4x 500 ng
RGD1311558-set siRNA/shRNA/RNAi Lentivector (Rat)
Sign In for Pricing
View Details LV655448 1.0 µg DNA
Car12 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA)
Sign In for Pricing
View Details